Cardiovascular abnormalities in systemic lupus erythematosus patients in echocardiographic assessment;Zmiany w układzie sercowo-naczyniowym u chorych na toczeń rumieniowaty układowy w oparciu o badania echokardiograficzne

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 305-308

  Ostanek, Lidia ^a   Płońska, Edyta ^a   Peregud Pogorzelska, Małgorzata ^a   Mokrzycki, Krzysztof ^a   Brzosko, Marek ^a   Fischer, Katarzyna ^a   Fliciński, Jacek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Antiphospholipid antibodies; Heart abnormalities; Serological risk factor; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; ENDOTHELIAL CELL ANTIBODY; EXTRACTABLE NUCLEAR ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AORTA DISEASE; ARTICLE; BLOOD VESSEL WALL; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MUSCLE; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; PATHOGENESIS; PERICARDIAL DISEASE; PERICARDITIS; RISK FACTOR; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 33645699803     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bulkley B.H., Roberts W.C.: The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am. J. Med., 1975, 58, 243-64.
2. Doherty N.E., Siegel R.J.: Cardiovascular manifestations of systemic lupus erythematosus. Am. Heart J., 1985, 110, 1257-65.
3. Galve E., Candell-Riera J., Pigrau C., i wsp.: Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N. Engl. J. Med., 1988, 319, 817-23.
4. Jensen-Urstad K., Svenungsson E., de Faire U., i wsp.: Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus., 2002, 11, 744-52.
5. Jouhikainen T., Pohjola-Sintonen S., Stephansson E.: Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus, 1994, 3, 167-72.
6. Leszczynski P., Straburzynska-Migaj E., Korczowska I., i wsp.: Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Clin. Rheumatol., 2003, 22, 405-8.
7. Manzi S., Meilahn E.N., Rairie J.E., i wsp.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol., 1997, 145, 408-15.
8. Moder K.G., Miller T.D., Tazelaar H.D.: Cardiac involvement in systemic lupus erythematosus. Mayo Clin. Proc., 1999, 74, 275-84.
9. Nihoyannopoulos P., Gomez P.M., Joshi J., i wsp.: Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation, 1990, 82, 369-75.
10. Straburzynska-Migaj E., Leszczynski P., Piszczek I., i wsp.: Echocardiographic heart assessment in systemic lupus erythematosus. Pol. Merkuriusz Lek., 1997, 3, 76-8.